How Much Can Boston Scientific's Cardiac Rhythm Management Business Grow In The Near Term?

Boston Scientific's (NYSE:BSX) Cardiac Rhythm Management business accounts for roughly 20% of the company's value, according to Trefis estimates. It includes products such as pacemakers and implantable cardioverter defibrillators (ICDs) that are used to treat abnormal heart conditions. Cardiac ...